Celgene, which is working on multiple fronts in the frontier of CAR-T drugs, says it has completed the first phase of a new manufacturing facility to produce the drug candidate it is developing with partner Bluebird Bio.Original Article
Celgene completes first phase of manufacturing facility for CAR-T effort with Bluebird Bio
